当前位置: X-MOL 学术Annu. Rev. Biochem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
At the Intersection of Chemistry, Biology, and Medicine
Annual Review of Biochemistry ( IF 16.6 ) Pub Date : 2017-06-27 00:00:00 , DOI: 10.1146/annurev-biochem-110716-121241
Christopher T. Walsh 1
Affiliation  

After an undergraduate degree in biology at Harvard, I started graduate school at The Rockefeller Institute for Medical Research in New York City in July 1965. I was attracted to the chemical side of biochemistry and joined Fritz Lipmann's large, hierarchical laboratory to study enzyme mechanisms. That work led to postdoctoral research with Robert Abeles at Brandeis, then a center of what, 30 years later, would be called chemical biology. I spent 15 years on the Massachusetts Institute of Technology faculty, in both the Chemistry and Biology Departments, and then 26 years on the Harvard Medical School Faculty. My research interests have been at the intersection of chemistry, biology, and medicine. One unanticipated major focus has been investigating the chemical logic and enzymatic machinery of natural product biosynthesis, including antibiotics and antitumor agents. In this postgenomic era it is now recognized that there may be from 105 to 106 biosynthetic gene clusters as yet uncharacterized for potential new therapeutic agents.

中文翻译:


在化学,生物学和医学交叉口

在哈佛大学获得生物学学士学位后,我于1965年7月在纽约洛克菲勒医学研究所开始了研究生院。我被生物化学的化学领域所吸引,并加入了弗里茨·利普曼(Fritz Lipmann)的大型分层实验室来研究酶的机制。这项工作导致了在布兰代斯(Brandeis)的罗伯特·阿贝尔斯(Robert Abeles)进行博士后研究,然后在30年后将其称为化学生物学的中心。我在麻省理工学院化学和生物学系任教15年,然后在哈佛医学院任教26年。我的研究兴趣一直在化学,生物学和医学的交叉领域。一项未曾预料到的主要重点是研究天然产物生物合成的化学逻辑和酶促机制,包括抗生素和抗肿瘤药。在这个后基因组时代,现在认识到可能有十个5至10 6个生物合成基因簇尚未被潜在的新型治疗剂所表征。

更新日期:2017-06-27
down
wechat
bug